4//SEC Filing
ARGOS THERAPEUTICS INC 4
Accession 0001543053-17-000001
CIK 0001105533operating
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 3:57 PM ET
Size
6.9 KB
Accession
0001543053-17-000001
Insider Transaction Report
Form 4
Harrelson Lori R.
Vice President of Finance
Transactions
- Award
Common Stock
2017-01-20+3,694→ 33,699 total - Award
Stock Option (right to buy)
2017-01-20+50,000→ 50,000 totalExercise: $5.05Exp: 2027-01-19→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 20, 2017 and vests as to 25% of the shares underlying this option on January 1, 2018, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning January 1, 2018.
Documents
Issuer
ARGOS THERAPEUTICS INC
CIK 0001105533
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001105533
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 3:57 PM ET
- Size
- 6.9 KB